MARSHALL WACE, LLP

Holdings History for CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD)

Symbol: CRMD on Nasdaq
Investment type: Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.02%	-0.02%	$22,867,628	1,966,262	-1,507,232	-43%	$11.63	Q4 2025
30 Sep 2025	0.04%	+0.01%	$40,396,735	3,473,494	+893,518	+35%	$11.63	Q3 2025
30 Jun 2025	0.04%	+0.03%	$31,785,302	2,579,976	+2,349,451	+1019%	$12.32	Q2 2025
31 Mar 2025	0%	+0%	$1,420,034	230,525	+230,525	NEW	$6.16	Q1 2025
31 Dec 2024		-0%	$0	0	-161,755	-100%	$7.36	Q4 2024
30 Sep 2024	0%	+0%	$1,306,981	161,755	+9,480	+6.2%	$8.08	Q3 2024
30 Jun 2024	0%	+0%	$659,350	152,275	+79,619	+110%	$4.33	Q2 2024
31 Mar 2024	0%	-0%	$308,062	72,656	-390,350	-84%	$4.24	Q1 2024
31 Dec 2023	0%	-0%	$1,740,903	463,006	-451,163	-49%	$3.76	Q4 2023
30 Sep 2023	0.01%	-0%	$3,382,425	914,169	-524,709	-36%	$3.70	Q3 2023
30 Jun 2023	0.01%	+0.01%	$5,697,958	1,438,878	+1,237,479	+614%	$3.96	Q2 2023
31 Mar 2023	0%	+0%	$833,792	201,399	+48,024	+31%	$4.14	Q1 2023
31 Dec 2022	0%	+0%	$647,241	153,375	+110,298	+256%	$4.22	Q4 2022
30 Sep 2022	0%	-0%	$122,000	43,077	-101,114	-70%	$2.83	Q3 2022
30 Jun 2022	0%	+0%	$579,000	144,191	+110,536	+328%	$4.02	Q2 2022
31 Mar 2022	0%	+0%	$184,000	33,655	+33,655	NEW	$5.47	Q1 2022
31 Dec 2019		-0%	$0	0	-4,552	-100%	$7.36	Q4 2019
30 Sep 2019	0%	+0%	$29,000	4,552	+4,552	NEW	$6.37	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.